Glenn Reicin Quotes

We view this as a relatively uneventful quarter for Abbott. - Glenn Reicin

We think it is unlikely that these changes will modify purchasing and demand characteristics of medical devices. Hospitals have traditionally had little leverage in reducing device costs. - Glenn Reicin

We think investors will look past third-quarter guidance, as the company has historically been overly conservative, and react favorably to the quarter. - Glenn Reicin

We suspect that J&J will continue to pursue acquisitions, but none as large as Guidant. - Glenn Reicin

We believe it will be critical for BSX to carefully manage its interaction with the FDA. - Glenn Reicin

The proposed changes ... related to cardiac procedures are dramatic. - Glenn Reicin

The opportunity to expand into other markets could be significant. - Glenn Reicin

The device replacements will cause companies to forgo revenue producing replacement units in future years. - Glenn Reicin

Simply put, engineers were making decisions that senior management and physicians should have made. - Glenn Reicin

Results were dramatically lower than consensus estimates in both cases and reflect the challenges the company faces in rebuilding its CRM [cardiac rhythm management] business. - Glenn Reicin

Page 1 of 2

Next -> Last ->>